PMS2-associated Lynch syndrome: past, present and future

Carriers of any pathogenic variant in one of the MMR genes (path_MMR carriers) were traditionally thought to be at comparable risk of developing a range of different malignancies, foremost colorectal cancer (CRC) and endometrial cancer. However, it is now widely accepted that their cancer risk and c...

Full description

Saved in:
Bibliographic Details
Main Authors: Andini, Katarina (Author) , Nielsen, Maartje (Author) , Suerink, Manon (Author) , Helderman, Noah C. (Author) , Koornstra, Jan Jacob (Author) , Ahadova, Aysel (Author) , Kloor, Matthias (Author) , Mourits, Marian J.E. (Author) , Kok, Klaas (Author) , Sijmons, Rolf H. (Author) , Bajwa-ten Broeke, Sanne W. (Author)
Format: Article (Journal)
Language:English
Published: 21 February 2023
In: Frontiers in oncology
Year: 2023, Volume: 13, Pages: 1-12
ISSN:2234-943X
DOI:10.3389/fonc.2023.1127329
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.3389/fonc.2023.1127329
Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/articles/10.3389/fonc.2023.1127329
Get full text
Author Notes:Katarina D. Andini, Maartje Nielsen, Manon Suerink, Noah C. Helderman, Jan Jacob Koornstra, Aysel Ahadova, Matthias Kloor, Marian J.E. Mourits, Klaas Kok, Rolf H. Sijmons and Sanne W. Bajwa-ten Broeke

MARC

LEADER 00000caa a2200000 c 4500
001 1840950773
003 DE-627
005 20230706214108.0
007 cr uuu---uuuuu
008 230331s2023 xx |||||o 00| ||eng c
024 7 |a 10.3389/fonc.2023.1127329  |2 doi 
035 |a (DE-627)1840950773 
035 |a (DE-599)KXP1840950773 
035 |a (OCoLC)1389530935 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Andini, Katarina  |e VerfasserIn  |0 (DE-588)1285042859  |0 (DE-627)184095146X  |4 aut 
245 1 0 |a PMS2-associated Lynch syndrome  |b past, present and future  |c Katarina D. Andini, Maartje Nielsen, Manon Suerink, Noah C. Helderman, Jan Jacob Koornstra, Aysel Ahadova, Matthias Kloor, Marian J.E. Mourits, Klaas Kok, Rolf H. Sijmons and Sanne W. Bajwa-ten Broeke 
246 3 0 |a two 
264 1 |c 21 February 2023 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 31.03.2023 
520 |a Carriers of any pathogenic variant in one of the MMR genes (path_MMR carriers) were traditionally thought to be at comparable risk of developing a range of different malignancies, foremost colorectal cancer (CRC) and endometrial cancer. However, it is now widely accepted that their cancer risk and cancer spectrum range notably depending on which MMR gene is affected. Moreover, there is increasing evidence that the MMR gene affected also influences the molecular pathogenesis of Lynch syndrome CRC. Although substantial progress has been made over the past decade in understanding these differences, many questions remain unanswered, especially pertaining to path_PMS2 carriers. Recent findings show that, while the cancer risk is relatively low, PMS2-deficient CRCs tend to show more aggressive behaviour and have a worse prognosis than other MMR-deficient CRCs. This, together with lower intratumoral immune infiltration, suggests that PMS2-deficient CRCs might have more in common biologically with sporadic MMR-proficient CRCs than with other MMR-deficient CRCs. These findings could have important consequences for surveillance, chemoprevention and therapeutic strategies (e.g. vaccines). In this review we discuss the current knowledge, current (clinical) challenges and knowledge gaps that should be targeted by future studies. 
700 1 |a Nielsen, Maartje  |e VerfasserIn  |4 aut 
700 1 |a Suerink, Manon  |e VerfasserIn  |4 aut 
700 1 |a Helderman, Noah C.  |e VerfasserIn  |4 aut 
700 1 |a Koornstra, Jan Jacob  |e VerfasserIn  |4 aut 
700 1 |a Ahadova, Aysel  |d 1988-  |e VerfasserIn  |0 (DE-588)106835268X  |0 (DE-627)820167118  |0 (DE-576)427724783  |4 aut 
700 1 |a Kloor, Matthias  |d 1972-  |e VerfasserIn  |0 (DE-588)124552803  |0 (DE-627)363416609  |0 (DE-576)294228616  |4 aut 
700 1 |a Mourits, Marian J.E.  |e VerfasserIn  |4 aut 
700 1 |a Kok, Klaas  |e VerfasserIn  |4 aut 
700 1 |a Sijmons, Rolf H.  |e VerfasserIn  |4 aut 
700 1 |a Bajwa-ten Broeke, Sanne W.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in oncology  |d Lausanne : Frontiers Media, 2011  |g 13(2023) vom: Feb., Artikel-ID 1127329, Seite 1-12  |h Online-Ressource  |w (DE-627)684965518  |w (DE-600)2649216-7  |w (DE-576)35841184X  |x 2234-943X  |7 nnas  |a PMS2-associated Lynch syndrome past, present and future 
773 1 8 |g volume:13  |g year:2023  |g month:02  |g elocationid:1127329  |g pages:1-12  |g extent:12  |a PMS2-associated Lynch syndrome past, present and future 
856 4 0 |u https://doi.org/10.3389/fonc.2023.1127329  |x Resolving-System  |x Verlag  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/articles/10.3389/fonc.2023.1127329  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230331 
993 |a Article 
994 |a 2023 
998 |g 124552803  |a Kloor, Matthias  |m 124552803:Kloor, Matthias  |d 910000  |d 912000  |d 50000  |e 910000PK124552803  |e 912000PK124552803  |e 50000PK124552803  |k 0/910000/  |k 1/910000/912000/  |k 0/50000/  |p 7 
998 |g 106835268X  |a Ahadova, Aysel  |m 106835268X:Ahadova, Aysel  |d 910000  |d 912000  |e 910000PA106835268X  |e 912000PA106835268X  |k 0/910000/  |k 1/910000/912000/  |p 6 
999 |a KXP-PPN1840950773  |e 4300645280 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"12 S."}],"id":{"doi":["10.3389/fonc.2023.1127329"],"eki":["1840950773"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"PMS2-associated Lynch syndrome","title":"PMS2-associated Lynch syndrome","subtitle":"past, present and future"}],"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"21 February 2023"}],"relHost":[{"recId":"684965518","title":[{"title_sort":"Frontiers in oncology","title":"Frontiers in oncology"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2649216-7"],"eki":["684965518"],"issn":["2234-943X"]},"origin":[{"publisherPlace":"Lausanne","dateIssuedKey":"2011","dateIssuedDisp":"2011-","publisher":"Frontiers Media"}],"language":["eng"],"part":{"text":"13(2023) vom: Feb., Artikel-ID 1127329, Seite 1-12","extent":"12","pages":"1-12","year":"2023","volume":"13"},"pubHistory":["2011 -"],"note":["Gesehen am 07.11.13"],"disp":"PMS2-associated Lynch syndrome past, present and futureFrontiers in oncology","type":{"media":"Online-Ressource","bibl":"periodical"}}],"language":["eng"],"name":{"displayForm":["Katarina D. Andini, Maartje Nielsen, Manon Suerink, Noah C. Helderman, Jan Jacob Koornstra, Aysel Ahadova, Matthias Kloor, Marian J.E. Mourits, Klaas Kok, Rolf H. Sijmons and Sanne W. Bajwa-ten Broeke"]},"note":["Gesehen am 31.03.2023"],"recId":"1840950773","person":[{"display":"Andini, Katarina","given":"Katarina","family":"Andini","role":"aut"},{"given":"Maartje","display":"Nielsen, Maartje","family":"Nielsen","role":"aut"},{"given":"Manon","display":"Suerink, Manon","family":"Suerink","role":"aut"},{"role":"aut","family":"Helderman","display":"Helderman, Noah C.","given":"Noah C."},{"display":"Koornstra, Jan Jacob","given":"Jan Jacob","family":"Koornstra","role":"aut"},{"display":"Ahadova, Aysel","given":"Aysel","family":"Ahadova","role":"aut"},{"family":"Kloor","role":"aut","given":"Matthias","display":"Kloor, Matthias"},{"display":"Mourits, Marian J.E.","given":"Marian J.E.","family":"Mourits","role":"aut"},{"family":"Kok","role":"aut","given":"Klaas","display":"Kok, Klaas"},{"given":"Rolf H.","display":"Sijmons, Rolf H.","role":"aut","family":"Sijmons"},{"role":"aut","family":"Bajwa-ten Broeke","display":"Bajwa-ten Broeke, Sanne W.","given":"Sanne W."}]} 
SRT |a ANDINIKATAPMS2ASSOCI2120